Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ПЕПТИДНЫЕ ВАКЦИНЫ<.>)
Общее количество найденных документов : 36
Показаны документы с 1 по 20
 1-20    21-36 
1.
A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules // Biomaterials, 2009. Vol. 30, N 28.-С.5178-5186

2.
A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules // Biomaterials, 2009. Vol. 30, N 28.-С.5178-5186

3.
A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years // Proc. Nat. Acad. Sci. USA, 1994. Vol. 91, N 20.-С.9588-9592

4.
A potential peptide vaccine against two different strains of influenza virus isolated at intervals of about 10 years // Proc. Nat. Acad. Sci. USA, 1994. Vol. 91, N 20.-С.9588-9592

5.
AIDS-related developments.. // Appl. Genet. News, 1988. Vol. 8, N 10.-С.8-11

6.
Construction of candidate synthetic peptide vaccines for HIV-1 // Vaccines'94: Mod. Approaches New Vaccines Includ. Prev. AIDS. -Cold Spring Harbor (N.Y.), 1994.-С.147-153

7.
Construction of candidate synthetic peptide vaccines for HIV-1 // Vaccines'94: Mod. Approaches New Vaccines Includ. Prev. AIDS. -Cold Spring Harbor (N.Y.), 1994.-С.147-153

8.
CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines // J. Virol., 1999. Vol. 73, N 5.-С.4120-4126

9.
Berzofsky Jay A. Designing anti-viral synthetic peptide vaccines // J. Cell. Biochem., 1994, Suppl. 18С.-С.212

10.
Developing synthetic peptide vaccines for HIV-1 // Vaccines'95: Mol. Approaches Contr. Infec. Diseases. -Cold Spring Harbor (N. Y.), 1995.-С.135-142

11.
Developing synthetic peptide vaccines for HIV-1 // Vaccines'95: Mol. Approaches Contr. Infec. Diseases. -Cold Spring Harbor (N. Y.), 1995.-С.135-142

12.
Development of a synthetic peptide vaccine against measles: Protection against measles and canine distemper and bypass of suppression by maternal antibody // Vaccines'94. -Cold Spring Harbor (N.Y.), 1994.-С.41-45

13.
Development of a synthetic peptide vaccine against measles: Protection against measles and canine distemper and bypass of suppression by maternal antibody // Vaccines'94. -Cold Spring Harbor (N.Y.), 1994.-С.41-45

14.
Yanamishi Development of new vaccine manufacturing techniques // Asian Med. J., 1995. Vol. 38, N 1.-С.1-6

15.
Identification of T-cell epitopes from human rhinovirus for use in synthetic peptide vaccines // Vaccines'92: Mod. Approaches New Vaccines Inslund. Prev. AJDS. -Cold Spring Harbor (N. J.), 1992.-С.259-264

16.
Villarrubia Vicente G. Las nuavas vacunas y la respuesta inmunologica I: La memoria inmunologica. Respuesta humoral frente a respuesta celular // Med. clin., 1996. Vol. 107, N 4.-С.146-154

17.
Thabaut A. Les nouveaux vaccins // Lett. infec. microbiol. clin., 1992. Vol. 7, N 12.-С.413-415

18.
Melief C.J.M. Lessons from T cell responses to virus induced tumours for cancer eradication in general // New Look Tumour Immunol.. -Cold Spring Harbor (N. Y.), 1992.-С.81-99

19.
Mass spectrometry and peptide-based vaccine development // Clin. Pharmacol. and Ther., 2007. Vol. 82, N 6.-С.644-652

20.
Peptide immunization in humans: A combined CD8{+}/CD4{+} T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL) // Clin. and Exp. Immunol., 1996. Vol. 105, N 1.-С.18-25

 1-20    21-36 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)